Acute mania
Pro Research Analysisby 
Searched over 200M research papers for "acute mania"
Acute Mania: Insights from Recent Research
Neuropsychological Profile of Acute Mania
Prefrontal Cortex Involvement and Cognitive Deficits
Acute mania has been linked to specific neuropsychological deficits, particularly in verbal memory and sustained attention. A study comparing acutely manic inpatients with nonpsychiatric subjects found that deficits in these areas were the most significant indicators of manic performance. Interestingly, these deficits were more pronounced than those in traditional measures of prefrontal cortex integrity, such as attentional set shifting, planning, and working memory . This suggests that while the prefrontal cortex is involved, the ventral prefrontal cortex may not be the primary locus of pathology in acute mania.
Pharmacological Treatments for Acute Mania
Risperidone Efficacy and Safety
Risperidone has shown significant efficacy in treating acute mania. In a double-blind, placebo-controlled study involving 290 inpatients with bipolar I disorder, risperidone led to substantial improvements in Young Mania Rating Scale (YMRS) scores as early as the first week of treatment. The most common adverse effects were extrapyramidal symptoms, but overall, the treatment was well tolerated .
Aripiprazole as Monotherapy and Adjunctive Therapy
Aripiprazole, an atypical antipsychotic, has been effective in reducing manic symptoms in both adults and children/adolescents. However, its efficacy compared to other treatments like lithium and haloperidol showed no significant differences in reducing manic symptoms at three weeks. Aripiprazole was associated with more movement disorders and gastrointestinal disturbances compared to placebo .
Comparative Efficacy of Antipsychotics and Mood Stabilizers
A systematic review of randomized, placebo-controlled trials found that both antipsychotics and mood stabilizers are significantly more effective than placebo in treating acute mania. The review included studies on carbamazepine, haloperidol, lithium, olanzapine, quetiapine, risperidone, valproate semisodium, and aripiprazole. All these medications showed significant benefits in reducing mania scores, although some, like carbamazepine and lithium, were less well-tolerated .
Clinical Management and Treatment Algorithms
Harvard South Shore Program Algorithm
The Psychopharmacology Algorithm Project at the Harvard South Shore Program has developed a detailed algorithm for the pharmacotherapy of acute mania. For nonmixed mania, lithium is recommended as the first-line treatment, with second-generation antipsychotics like quetiapine or risperidone as adjuncts. For mixed mania, quetiapine is preferred due to its efficacy in treating depressive symptoms. The algorithm also considers the use of other medications like valproate, carbamazepine, and electroconvulsive therapy for treatment-resistant cases .
Symptomatology and Self-Rating Scales
Factor Analysis of Mania Symptoms
A factor analysis of acute mania symptoms identified three clinically meaningful subtypes: 'irritable mania,' 'elated mania,' and 'psychotic mania.' These subtypes were characterized by different symptom clusters, such as irritability and aggressive behavior for irritable mania, and elevated mood and thought disorder for elated mania. This multidimensional nature of manic symptoms suggests that different subtypes may respond differently to treatment .
Self-Rating Scales for Mania
In evaluating self-rating scales for acute mania, the Altman Self-Rating Mania Scale (ASRM) and the Self-Report Manic Inventory (SRMI) were found to be more sensitive than the Internal State Scale (ISS) in identifying patients with acute symptoms. All three scales were sensitive to treatment effects, but the ASRM and SRMI were particularly effective in screening for acute mania .
Conclusion
Recent research has provided valuable insights into the neuropsychological profile, pharmacological treatments, and clinical management of acute mania. Effective treatment options include antipsychotics like risperidone and aripiprazole, as well as mood stabilizers such as lithium and valproate. Understanding the multidimensional nature of manic symptoms and utilizing appropriate self-rating scales can further enhance the management of this complex condition.
Sources and full results
Most relevant research papers on this topic